Ray Amrit 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Jun 9, 2023
Insider Transaction Report
Form 4
Ray Amrit
Director
Transactions
- Award
Common Stock
2023-06-07+3,860→ 12,280 total - Award
Stock Option (Right to Buy)
2023-06-07+7,110→ 7,110 totalExercise: $51.82Exp: 2033-06-07→ Common Stock (7,110 underlying)
Footnotes (2)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024.
- [F2]The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024.